Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

BFIN, MFSF, BCDS, CRWE, PQRM - Stock Updates! from CRWEfinance.com

crwefinancelogo2

signup3m

___

crwe_logo_200x72   Crown Equity Holdings Inc. (OTCPK:CRWE)

With the growth of information on the internet has growth the amount of time people spend on it, which has in turn generated a new market for internet advertising. Some of the wealthiest companies in the world have made sure that they get a piece of the internet marketing pie, and for a good reason.

Crown Equity Holdings Inc. has extended its CRWENEWSWIRE global platform web presence and is now publishing online news and information to the following countries: Argentina, Australia, Brazil, Canada, China, France, Germany, India, Ireland, Italy, Japan, Malaysia, Mexico, New Zealand, Russia, Singapore, South Africa, South Korea, Spain, Taiwan, United Arab Emirates and the United Kingdom, using their specific country code domain and native language.

CRWE has also established over 1,100 city specific sites within the US, allowing CRWE to publish its news and information globally or geographically.

CRWE’s wholly owned subsidiary, Crown Tele Services Inc., has completed installing servers for its business, which is currently in the process of preparing to provide and offer its “VoIP” communication services to small, large and enterprise businesses.

Crown Equity Holdings Inc. is a consulting organization which provides and assists small business owners with the knowledge required in taking their company public, and has re-focused CRWE's primary vision with its aligned group of independent website divisions to providing media advertising services, as a worldwide online media advertising publisher, dedicated to the distribution of quality branding information, as well as search engine optimization for its clients.

To learn more about CRWE visit: http://www.crownequityholdings.com

*****

BankFinancial Corp. (Nasdaq:BFIN) announced that its Board of Directors has declared a cash dividend of $0.07 per common share. The dividend will be payable on March 4, 2011 to stockholders of record on February 9, 2011.

BankFinancial Corporation operates as the holding company for BankFinancial, F.S.B., which provides commercial, family, and personal banking services in Illinois. The company was founded in 1924 and is headquartered in Burr Ridge, Illinois.

*****

Mutualfirst Financial Inc. (Nasdaq:MFSF) will hold its annual meeting of stockholders at the Bank's headquarters at 110 E. Charles Street, Muncie, Indiana on April 27, 2011 at 3:00 p.m. local time. The Record Date for voting has been set for March 1, 2011.

MutualFirst Financial, Inc. operates as a holding company for MutualBank that provides banking services to individuals and businesses. It accepts various savings deposit accounts, NOW and demand accounts, and certificates of deposit.

*****

Power3 Medical Products, Inc. (OTC:PWRM)

After skin cancer, breast cancer is the most common malignancy recognized in females across the nation. Nevertheless, breast cancer levels have lowered in recent years, despite the fact that healthcare doctors are not specific about why. For lots of ladies, breast melanoma is actually the disease they fear the most.

Breast cancer is a type of cancer by which microscopic cells in the breast separate and develop without normal regulation. Approximately 85 percent of breast cancers begin in the actual mammary ducts, though about fifteen percent start within the lobules. Growths inside the breast have a tendency to increase bit by bit. By the time a mass can be large enough so that you can feel it, the cancer may have been growing as long as 10 years. However, some tumors may be aggressive, and expand a lot more rapidly.

Breast cancer is melanoma originating out of breasts cells, most often from the inner lining of milk ducts or the lobules that supply the ducts with milk. Cancers via ducts are known as ductal carcinomas; those beginning in lobules are known as lobular carcinomas.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.

Drug Resistance to Chemotherapeutic Agents in Cancer

Power3's technology has the potential to be used to develop new drugs based upon the precise differences between diseased-related and healthy-related protein footprints. New drugs can be engineered to hone in on the changed protein structures and alter them. Power3 uses proteomics for the specific identification of proteins involved in a disease to provide usable products to address unmet needs and new treatment options. This platform has specific application in the area of drug resistance to chemotherapeutic agents in cancer. By the time development of resistance to chemotherapeutic agents is detected, it is usually too late to save the patient. Power3's technology can be used to detect drug resistance before treatment and engineer drugs to kill both sensitive and resistant cancer to prevent recurrence.

Power3 completed an initial proof of concept that addresses drug resistance to a major chemotherapy agent. Knowing if a cancer patient is sensitive or detecting earlier the development of resistance during treatment could eliminate toxic effects, trial-and-error treatment regimens and save the patient. These findings have the potential to change existing treatment algorithms and will yield significant value. The pharmaceutical industry will then gain the technology to screen patients, on a molecular level, prior to clinical trials and will design new drugs to overcome resistance. Power3 management believes this technology will increase the success rates of chemotherapy agents and eliminate futile treatments early in the clinical trials, saving lives and significant financial resources.

To learn more about PWRM visit: http://www.Power3Medical.com

*****

BCD Semiconductor Manufacturing (Nasdaq:BCDS) released its financial results for the fiscal fourth quarter and the fiscal year ended December 31, 2010 this week. The press release was followed by a conference call and live webcast. To listen to the live conference call, please dial 866-242-1388 (or 61 2 8823 6760 if dialing from outside the U.S.A.). The conference ID number is 40353872. The webcast replay will be available for seven days after the live call on the company's investor relations website at:  http://ir.bcdsemi.com. To listen to the webcast replay, please dial 866-214-5335 (or 61 2 8235 5000 if dialing from outside the U.S.A.) The conference ID number for the replay is 40353872.

BCD Semiconductor Manufacturing Limited engages in the design, manufacture, and sale of power management analog integrated circuits (ICs) and other semiconductor devices in the People's Republic of China.

___

********************************************************************

http://crwefinance.com/img/crwefinance_new_buscard2.jpg

Signup for FREE Daily Stock Alerts From CRWEFinance.com/signup

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock.  Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM).